Paper Details

  1. Home
  2. Paper Details

Prognostic factors of good response to DMARDs in psoriatic arthritis: a narrative review.

Author: ChoukMickaël, MekhailChristine, PratiClément, VerhoevenFrank, WendlingDaniel

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

A review of literature on psoriatic arthritis (PsA) treatment suggests that dactylitis and axial involvement are associated with poor response to methotrexate, leflunomide is more effective in polyarticular involvement, TNF inhibitors are preferred for young men with elevated CRP, and apremilast and ustekinumab are more effective in mono and oligo articular disease.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: The management of Psoriatic arthritis (PsA) has evolved in the last decade with a significant increase in treatment options making the choice for clinicians difficult. Thus, the different factors of good prognosis for each treatment are presented in this review. AREAS COVERED: Current...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/17512433.2020.1758556

データ提供：米国国立医学図書館（NLM）

Unlocking the Secrets of DMARDs: Who Benefits Most?

The management of [psoriatic arthritis (PsA)] has become more sophisticated, with a wide range of treatment options available. This narrative review explores the factors that contribute to a [good response to disease-modifying antirheumatic drugs (DMARDs)] in PsA. The authors present a comprehensive overview of [current treatment and assessment tools] for [PsA], discussing the prognostic factors associated with a [good response to csDMARDs, tsDMARDs, and bDMARDs]. The review provides valuable guidance for clinicians in making informed decisions about treatment choices for patients with PsA.

Unlocking the Secrets of DMARDs: Who Benefits Most?

This review highlights the importance of considering [individual patient characteristics] when selecting a [DMARD] for PsA. Identifying factors that predict a good response to specific therapies can lead to more effective treatment plans and improved patient outcomes. Further research is needed to refine these prognostic factors and to explore personalized approaches to [DMARD] therapy for PsA.

Unlocking the Secrets of DMARDs: Who Benefits Most?

If you're living with PsA, it's crucial to work closely with your healthcare provider to develop a treatment plan that's tailored to your individual needs. By understanding the factors that influence [DMARD] efficacy, you can make informed decisions about your treatment options and work towards achieving long-term relief from your symptoms.

Dr. Camel's Conclusion

This review, like a skilled navigator guiding a caravan through the desert, reveals the complexities of [DMARD] therapy for PsA. The authors have provided a valuable roadmap for clinicians, highlighting factors that can predict a [good response to treatment]. The journey towards optimal care for PsA requires a personalized approach, taking into account individual patient characteristics and tailoring treatment plans to maximize effectiveness.

Date :
  1. Date Completed 2021-01-20
  2. Date Revised 2022-04-15
Further Info :

Pubmed ID

32306777

DOI: Digital Object Identifier

10.1080/17512433.2020.1758556

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.